Medifarm and Tikun Olam share a passion for helping patients with medicinal cannabis medicines. While Medifarm, has changed its name, we remain 100% Australian.
In 2016, the Australian Government was gearing up to amend the Narcotic Drugs Act 1967 to enable the cultivation of cannabis for medical and related research purposes with licensing changes set to come into effect on October 30, 2016. The Government roadshows held throughout 2016 set the stage for the current prescription-based treatment method.
Medifarm sought and gained the necessary Australian licensing for medicinal cannabis cultivation, manufacturing and research on the Sunshine Coast; partnered with Tikun Olam a company who shared the vision for helping patients with the medicines, backed by strong research.
Although now, a global company, Tikun Olam started as a family built non-for-profit company. Since its inception more than 15 years ago they have been dedicated to assisting patients globally. As pioneers in medicinal cannabis research, they have performed extensive clinical trials and assisted over 30,000 patients through their broad network of clinics. Tikun Olam have built their reputation on examining the therapeutic effects of specific cannabis strains. They collaborate with global experts in medicinal cannabis cultivation, research, treatment development and are committed to ensuring treatment quality and consistency.
At Tikun Australia each team member contributes having either experienced their own health challenges and/or have a story to share of a friend, family member or a member of the community. We are passionate about what we do.
Although the Australian medicinal cannabis industry is relatively new the practices of cultivation and manufacturing are not, we have an outstanding team who bring with them knowledge and experience, across a multitude of departments.